MedTrace Logo

Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress

NCT02184507 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2014-10-24

No results posted yet for this study

Summary

The present study aimed to evaluate the effect of a combination of insulin resistance reducing agents pre and post coronary artery bypass grafting surgery on post-operative blood glucose and oxidative stress regulation.

Conditions

Interventions

DIETARY_SUPPLEMENT

Supplement pre CABG

One sachet of the supplement was consumed daily for 7 days before surgery.

DIETARY_SUPPLEMENT

Supplement post CABG

One sachet of the supplement was consumed daily for 30 days after surgery

DIETARY_SUPPLEMENT

Supplement pre and post CABG

One sachet of the supplement was consumed daily for 7 days before surgery and 30 days after CABG

DRUG

Placebo

One sachet of placebo was consumed daily for 7 days before surgery and 30 days after CABG

Sponsors & Collaborators

  • Shiraz University of Medical Sciences

    collaborator OTHER

  • Mohammad Hassan Eftekhari

    lead OTHER

Principal Investigators

  • Mohammad Hassan Eftekhari, professor · Shiraz University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-03-31
Completion
2014-07-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02184507 on ClinicalTrials.gov